Terns Pharmaceuticals in 1 story
The narratives TERN currently appears in, with its side and exposure in each.
Bull side
1 story- GLP-1 Eats Everything
TERN in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
Terns is developing the oral GLP-1 candidate TERN-601, making it a direct small-cap play on more convenient obesity therapy.
Bear side
0 storiesNo bear-side stories for TERN yet.